Friday, August 4, 2017

United Therapeutics stock up 9 percent on GSK acquisition report

Silver Spring-based United Therapeutics Corp.’s stock jumped Friday following a report that GlaxoSmithKline PLC or other drug giants may be looking to acquire it. According to a report from the Evening Standard in London on Friday, GSK may be eying United Therapeutics in deal worth nearly $9 billion, or $200 a share. Other potential suitors include Gilead Sciences Inc. and Novartis AG. United Therapeutics’ share price jumped more than 9 percent on the report from a previous close of $126.96 to…


No comments:

Post a Comment